Intracanalicular Dexamethasone Insert for the Treatment of Inflammation and Discomfort in Dry Eye Disease (DEcIDED)

Summary

This prospective, single-center, randomized, double-masked, parallel comparison, sponsored study seeks to investigate the efficacy of Intracanalicular dexamethasone Insert (IDI) on ameliorating the signs and symptoms of dry eye disease.

Timeline

Start

2020-09-04

Primary completion

2023-11-17

Completion

2024-12-31

Outcome

Outcome not reported

Stopped (Enrollment): “Per sponsor decision due to lengthy enrollment period”

Drugs

Indications